Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Conference News AHA 2024

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Michael O'Riordan

November 21, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

Presentation AHA 2024

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Presenter: Kausik K. Ray

November 17, 2024

News Conference News AHA 2024

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Michael O'Riordan

November 15, 2024

Presentation AHA 2023

MINT: Myocardial Ischemia and Transfusion

Presenter: Jeffrey L Carson

November 13, 2023

News Conference News AHA 2023

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

L.A. McKeown

November 11, 2023

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

News Conference News AHA 2021

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Michael O'Riordan

November 22, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Conference News AHA 2020

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

Todd Neale

November 17, 2020

News Conference News AHA 2020

Childhood Stress, Trauma Linked to Worse Outcomes After Early MI

L.A. McKeown

November 16, 2020

News Conference News AHA 2020

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

Todd Neale

November 15, 2020

News Conference News AHA 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Michael O'Riordan

November 12, 2020

News Conference News AHA 2019

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Todd Neale

November 20, 2019

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News AHA 2018

Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab

Yael L. Maxwell

November 10, 2018

News Conference News AHA 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Michael O'Riordan

November 10, 2018

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Conference News AHA 2017

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Michael O'Riordan

November 14, 2017

Advertisement

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

MINT: Myocardial Ischemia and Transfusion

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

ApoB Gains Ground as Best Lipid Predictor of MI Risk

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

Childhood Stress, Trauma Linked to Worse Outcomes After Early MI

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content